The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein‐22

To assess atypical cytology as a positive bladder tumour marker and to determine if indexing atypical cytology to nuclear matrix protein‐22 (NMP22) can decrease the false‐positive results or increase the positive predictive value (PPV).

[1]  C. Zippe,et al.  Screening and monitoring for bladder cancer: refining the use of NMP22. , 2001, The Journal of urology.

[2]  A. K. Agarwal,et al.  Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat. , 1999, The Journal of urology.

[3]  A. Agarwal,et al.  NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer. , 1999, Anticancer research.

[4]  D J O'Kane,et al.  Comparison of screening methods in the detection of bladder cancer. , 1999, The Journal of urology.

[5]  J. Stern,et al.  Cost-effective evaluation of indeterminate urinary cytology. , 1998, The Journal of urology.

[6]  M. Marberger,et al.  Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? , 1998, The Journal of urology.

[7]  P. Schellhammer,et al.  Improved detection of recurrent bladder cancer using the Bard BTA stat Test. , 1998, Urology.

[8]  R. Clayman,et al.  Incisional hernia after laparoscopic nephrectomy with intact specimen removal: caveat emptor. , 1997, The Journal of urology.

[9]  S. Ishikawa,et al.  [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]. , 1997, Gan to kagaku ryoho. Cancer & chemotherapy.

[10]  E. Messing,et al.  Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. , 1996, The Journal of urology.

[11]  G. Farrow.  Urine cytology in the detection of bladder cancer: a critical approach. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[12]  Marek Kimmel,et al.  The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma , 1987, Cancer.

[13]  O. Yoshida,et al.  Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. , 1998, The Journal of urology.

[14]  R. Dodge,et al.  Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. , 1994, The Journal of urology.

[15]  T. Ushiyama,et al.  [Survival rate of bladder tumors--an analysis of 2304 patients with bladder tumors in the Tokai Urological Cancer Registry]. , 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.